Cerebrovascular accidents (CVA) are the leading cause of disabilities in the world. Only 15% of people with hemiparesis after a CVA regain prehensile function. Early neurorehabilitation therefore plays a crucial role here. Its effectiveness on functional recovery after a CVA has been demonstrated and holds true for any patient with brain damage. Quality of grip greatly depends on the capacity to open the hand, as patients with hemiparesis mostly have difficulty letting go of objects or in the approach.
The project will acquire two Bioness 200 neurostimulation braces that foster grip rehabilitation. These devices have proven their merit since a decade ago in North America and are used by numerous neurorehabilitation therapists to complement treatments. For the 800 people in Geneva each year who have a CVA and are admitted to the HUG’s neurovascular unit, the project encourages early treatment of sensory motor issues. This treatment is supported by experienced therapists and cutting-edge technology, and it helps the patient to maintain an active role in dealing with their illness.
Mr. Fabien Albert, Team Manager, Neurorehabilitation Division, Department of Clinical Neurosciences, Geneva University Hospitals